Written question asked by Ian Gibson (Labour) on Thursday, 24 October 2002, in the House of Commons. It was due for an answer on Thursday, 7 November 2002. It was answered by Hazel Blears (Labour) on Thursday, 7 November 2002 on behalf of the Department of Health.
Dept of Health
- Question
- To ask the Secretary of State for Health, what assessment he has made of the impact of the patents on breast cancer genes owned by Myriad Inc on testing for hereditary breast cancer; and what negotiations his Department is involved in with Myriad on this issue.
- Answer
-
Dr. Gibson: To ask the Secretary of State for Health what assessment he has made of the impact of the patents on breast cancer genes owned by Myriad Inc on testing for hereditary breast cancer; and what negotiations his Department is involved in with Myriad on this issue. [77878] Ms Blears: The Department is still in discussion with Myriad and the discussion is confidential at this stage.
Secondary information
- Type
- Written question
- Reference
- 77878; 392 c517W;392 c529W
- Session
- 2001-02
- Subjects
- Breast cancer Genetics Hereditary diseases Patents Screening Research Myriad Genetics
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2016-10-07 16:03:09 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_718838
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_718838
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_718838